sct650c
mAbexperimental
Clinical trial activity
3 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Jun 30, 2023 (NCT05894707)
Timeline
Indications
Mechanism of action
- Interleukin 17AINHIBITOR
IL17A inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07244510 | Phase 2 | Nov 18, 2025 | Sinocelltech Ltd. |
| NCT06197009 | Phase 2 | Jul 1, 2024 | Sinocelltech Ltd. |
| NCT05894707 | Phase 1 | Jun 30, 2023 | Linear Clinical Research, Sinocelltech Ltd. |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Sinocelltech Ltd. | For profit | 3 | 3 | 2 | 2023 |
| Linear Clinical Research | For profit | 1 | 0 | 1 | 2023 |
2 organizations
Page 1 / 1